Purpose
The aim of the study is to evaluate the effects of targeting the antivascular drug combretastatin to irradiated mouse melanomas.
Methods
Combretastatin was incorporated into liposomes with surfaces modified by the addition of cyclo(Arg-Gly-Asp-d-Phe-Cys) (RGD) to create an immunoliposome (IL). This addition of RGD allows the liposome to be preferentially targeted to αvβ3, an integrin up-regulated in the vasculature of irradiated tumors. C57BL mice bearing a transplanted B16-F10 melanoma were randomly assigned to one of the following treatment groups: untreated, a single dose of 5-Gy radiation (IR), IL (14.5 mg/kg of combretastatin), 5-Gy radiation plus IL, and a systemic administration of free drug (81.0 mg/kg of combretastatin).
Results
In this transplanted tumor model, there was no significant increase in the volume of the IL + IR (5 Gy) treated tumors during the initial 6 days posttreatment; all other treatment groups exhibited exponential growth curves after day 3. The IL + IR (5 Gy) treatment resulted in a 5.1-day tumor growth delay compared to untreated controls.
Conclusions
These findings indicate that preferential targeting of antivascular drugs to irradiated tumors results in significant tumor growth delay.
Similar content being viewed by others
References
D. J. Chaplin G. J. Dougherty (1999) ArticleTitleTumour vasculature as a target for cancer therapy Br. J. Cancer 80 IssueIDSuppl. 1 57–64
B. J. Moeller Y. Cao C. Y. Li M. W. Dewhirst (2004) ArticleTitleRadiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules Cancer Cell 5 429–441
S. L. Young D. J. Chaplin (2004) ArticleTitleCombretastatin A4 phosphate: background and current clinical status Expert Opin. Investig. Drugs 13 1171–1182
W. Landuyt B. Ahmed S. Nuyts J. Theys D. B. Op A. Rijnders J. Anne A. Oosterom Particlevan B. W. den Particlevan den P. Lambin (2001) ArticleTitleIn vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment Int. J. Radiat. Oncol. Biol. Phys. 49 443–450
E. E. Burch V. R. Patil R. T. Camphausen M. F. Kiani D. J. Goetz (2002) ArticleTitleThe N-terminal peptide of PSGL-1 can mediate adhesion to trauma-activated endothelium via P-selectin in vivo Blood 100 531–538
H. S. Sakhalkar M. K. Dalal A. K. Salem R. Ansari J. Fu M. F. Kiani D. T. Kurjiaka J. Hanes K. M. Shakesheff D. J. Goetz (2003) ArticleTitleLeukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo Proc. Natl. Acad. Sci. USA 100 15895–15900
G. Bendas A. Krause R. Schmidt J. Vogel U. Rothe (1998) ArticleTitleSelectins as new targets for immunoliposome-mediated drug delivery. A potential way of anti-inflammatory therapy Pharm. Acta Helv. 73 19–26
D. Hallahan L. Geng S. Qu C. Scarfone T. Giorgio E. Donnelly X. Gao J. Clanton (2003) ArticleTitleIntegrin-mediated targeting of drug delivery to irradiated tumor blood vessels Cancer Cell 3 63–74
H. Yuan, D. J. Goetz, M. W. Gaber, A. C. Issekutz, T. E. Merchant, and M. F. Kiani. Radiation induced upregulation of adhesion molecules in brain microvasculature and their modulation by dexamethasone. Radiat. Res. (2005).
M. F. Kiani H. Yuan X. Chen L. Smith M. W. Gaber D. J. Goetz (2002) ArticleTitleTargeting microparticles to select tissue via radiation-induced upregulation of endothelial cell adhesion molecules Pharm. Res. 19 1317–1322
J. S. Kerr A. M. Slee S. A. Mousa (2002) ArticleTitleThe alpha v integrin antagonists as novel anticancer agents: an update Expert Opin. Investig. Drugs 11 1765–1774
D. E. Hallahan L. Geng A. J. Cmelak A. B. Chakravarthy W. Martin C. Scarfone A. Gonzalez (2001) ArticleTitleTargeting drug delivery to radiation-induced neoantigens in tumor microvasculature J. Control. Rel. 74 183–191
L. Li C. A. Wartchow S. N. Danthi Z. Shen N. Dechene J. Pease H. S. Choi T. Doede P. Chu S. Ning D. Y. Lee M. D. Bednarski S. J. Knox (2004) ArticleTitleA novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles Int. J. Radiat. Oncol. Biol. Phys. 58 1215–1227
R. E. Seftor E. A. Seftor K. R. Gehlsen W. G. Stetler-Stevenson P. D. Brown E. Ruoslahti M. J. Hendrix (1992) ArticleTitleRole of the alpha v beta 3 integrin in human melanoma cell invasion Proc. Natl. Acad. Sci. USA 89 1557–1561
G. R. Pettit S. B. Singh G. M. Cragg (1985) ArticleTitleSynthesis of natural (−)-combretastatin J. Org. Chem. 50 3404–3406
S. B. Singh G. R. Pettit (1989) ArticleTitleIsolation, structure, and synthesis of combretastatin C-1 J. Org. Chem. 54 4105–4114
G. R. Pettit S. B. Singh M. R. Boyd E. Hamel R. K. Pettit J. M. Schmidt F. Hogan (1995) ArticleTitleAntineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a) J. Med. Chem. 38 1666–1672
C. B. Hansen G. Y. Kao E. H. Moase S. Zalipsky T. M. Allen (1995) ArticleTitleAttachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures Biochim. Biophys. Acta 1239 133–144
W. Landuyt O. Verdoes D. O. Darius M. Drijkoningen S. Nuyts J. Theys L. Stockx W. Wynendaele J. F. Fowler G. Maleux B. W. den Particlevan den J. Anne A. Oosterom Particlevan P. Lambin (2000) ArticleTitleVascular targeting of solid tumours: a major ‘inverse’ volume-response relationship following combretastatin A-4 phosphate treatment of rat rhabdomyosarcomas Eur. J. Cancer 36 1833–1843
M. Sayed Particleel M. F. Kiani M. D. Naimark A. H. Hikal H. Ghandehari (2001) ArticleTitleExtravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium Pharm. Res. 18 23–28
D. D. Spragg D. R. Alford R. Greferath C. E. Larsen K. D. Lee G. C. Gurtner M. I. Cybulsky P. F. Tosi C. Nicolau M. A. Gimbrone SuffixJr (1997) ArticleTitleImmunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system Proc. Natl. Acad. Sci. USA 94 8795–8800
M. A. der Particlevan der M. Vandamme C. Squiban M. H. Gaugler M. A. Mouthon (2003) ArticleTitleInflammatory reaction and changes in expression of coagulation proteins on lung endothelial cells after total-body irradiation in mice Radiat. Res. 160 637–646
Acknowledgments
This work was supported by NSF Grant BES0090009 and the Scholler Foundation. Mohammad F. Kiani is an Established Investigator of the American Heart Association. We would like to thank Dr. Stanley Kosanke (the University of Oklahoma Health Science Center) for performing the pathological examination of the tumors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pattillo, C.B., Sari-Sarraf, F., Nallamothu, R. et al. Targeting of the Antivascular Drug Combretastatin to Irradiated Tumors Results in Tumor Growth Delay. Pharm Res 22, 1117–1120 (2005). https://doi.org/10.1007/s11095-005-5646-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-005-5646-0